Ertapenem for the treatment of Hidradenitis suppurativa: how much do we need it?

array:24 ["pii" => "S1578219018301938" "issn" => "15782190" "doi" => "10.1016/j.adengl.2018.06.001" "estado" => "S300" "fechaPublicacion" => "2018-09-01" "aid" => "1953" "copyright" => "Elsevier España, S.L.U. and AEDV" "copyrightAnyo" => "2018" "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Actas Dermosifiliogr. 2018;109:582-3" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S0001731018301789" "issn" => "00017310" "doi" => "10.1016/j.ad.2018.03.012" "estado" => "S300" "fechaPublicacion" => "2018-09-01" "aid" => "1953" "copyright" => "AEDV" "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Actas Dermosifiliogr. 2018;109:582-3" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 168 "formatos" => array:2 [ "HTML" => 113 "PDF" => 55 ] ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "Artículo de opinión" "titulo" => "Ertapenem para el tratamiento de hidradenitis supurativa: ¿en qué medida lo necesitamos?" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "582" "paginaFinal" => "583" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Ertapenem for the treatment of Hidradenitis suppurativa: how much do we need it?" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "P. Mendes-Bastos, A. Martorell, S. Magina" "autores" => array:3 [ 0 => array:2 [ "nombre" => "P." "apellidos" => "Mendes-Bastos" ] 1 => array:2 [ "nombre" => "A." "apellidos" => "Martorell" ] 2 => array:2 [ "nombre" => "S." "apellidos" => "Magina" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S1578219018301938" "doi" => "10.1016/j.adengl.2018.06.001" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219018301938?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731018301789?idApp=UINPBA000044" "url" => "/00017310/0000010900000007/v1_201809020415/S0001731018301789/v1_201809020415/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S1578219018302324" "issn" => "15782190" "doi" => "10.1016/j.adengl.2018.06.020" "estado" => "S300" "fechaPublicacion" => "2018-09-01" "aid" => "1954" "copyright" => "Elsevier España, S.L.U. and AEDV" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Actas Dermosifiliogr. 2018;109:584-601" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 6 "formatos" => array:2 [ "HTML" => 1 "PDF" => 5 ] ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "Special article" "titulo" => "Prevention and treatment of tuberculosis infection in candidates for biologic therapy: A multidisciplinary consensus statement adapted to the dermatology patient" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "584" "paginaFinal" => "601" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Consenso multidisciplinar sobre prevención y tratamiento de la tuberculosis en pacientes candidatos a tratamiento biológico. Adaptación al paciente dermatológico" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0020" "etiqueta" => "Figure 4" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr4.jpeg" "Alto" => 1998 "Ancho" => 2088 "Tamanyo" => 209567 ] ] "descripcion" => array:1 [ "en" => "Provisional algorithm for assessment of TB infection in candidates for anti-TNF treatment. a Appropriate treatment for TB is defined as ≥6 months of treatment with first-line drugs, including ≥2 months of the combination of rifampicin, isoniazid, pyrazinamide and ethambutol. Appropriate treatment for latent infection can be administration of ≥6 months of isoniazid, 3 months of isoniazid and rifampicin, or 4 months of rifampicin alone. b The risk of latent infection is determined by weighting factors such as exposure to known contagious case, age, country of origin, and work and social history of the individual, including travel to endemic countries and repeated exposure to collectives at risk (closed institutions, homeless, drug users). c In those infected many years earlier, TT can be negative and become positive in a second TT (booster phenomenon). With the availability of IGRAs, it would seem more practical to use these as complementary tests rather than performing a second TT, both in patients aged more than 60 years and in immunosuppressed patients due to different causes, regardless of age. d There are no conclusive data to establish a safe period between the start of treatment for latent infection and the start of anti-TNF therapy. Four weeks delay is considered usual practice and safe by most experts. eActive TB treatment should be completed before starting biological therapy. See text for interpretation and extension of this algorithm. Anti-TNF, anti-tumor necrosis factor; BCG, bacillus Calmette-Guerin; IGRA, interferon γ release assay; TB, tuberculosis; TT, tuberculin test. Source: Adapted from Winthrop..<a class="elsevierStyleCrossRef" href="#bib1200">120</a>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "P. Rodríguez-Jiménez, I. Mir-Viladrich, P. Chicharro, G. Solano-López, F.J. López-Longo, C. Taxonera, P. Sánchez-Martínez, X. Martínez-Lacasa, M. García-Gasalla, J. Dorca, M. Arias-Guillén, J.M. García-García, E. Dauden" "autores" => array:13 [ 0 => array:2 [ "nombre" => "P." "apellidos" => "Rodríguez-Jiménez" ] 1 => array:2 [ "nombre" => "I." "apellidos" => "Mir-Viladrich" ] 2 => array:2 [ "nombre" => "P." "apellidos" => "Chicharro" ] 3 => array:2 [ "nombre" => "G." "apellidos" => "Solano-López" ] 4 => array:2 [ "nombre" => "F.J." "apellidos" => "López-Longo" ] 5 => array:2 [ "nombre" => "C." "apellidos" => "Taxonera" ] 6 => array:2 [ "nombre" => "P." "apellidos" => "Sánchez-Martínez" ] 7 => array:2 [ "nombre" => "X." "apellidos" => "Martínez-Lacasa" ] 8 => array:2 [ "nombre" => "M." "apellidos" => "García-Gasalla" ] 9 => array:2 [ "nombre" => "J." "apellidos" => "Dorca" ] 10 => array:2 [ "nombre" => "M." "apellidos" => "Arias-Guillén" ] 11 => array:2 [ "nombre" => "J.M." "apellidos" => "García-García" ] 12 => array:2 [ "nombre" => "E." "apellidos" => "Dauden" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0001731018301790" "doi" => "10.1016/j.ad.2018.03.013" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731018301790?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219018302324?idApp=UINPBA000044" "url" => "/15782190/0000010900000007/v1_201809020417/S1578219018302324/v1_201809020417/en/main.assets" ] "itemAnterior" => array:18 [ "pii" => "S1578219018302208" "issn" => "15782190" "doi" => "10.1016/j.adengl.2018.06.009" "estado" => "S300" "fechaPublicacion" => "2018-09-01" "aid" => "1859" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Actas Dermosifiliogr. 2018;109:581" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 4 "formatos" => array:2 [ "HTML" => 3 "PDF" => 1 ] ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "Comentarios Editoriales" "titulo" => "Role of Color Doppler Ultrasound in the Diagnosis of Idiopathic Facial Aseptic Granuloma" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "581" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Papel de la ecografía doppler color en el diagnóstico de granuloma aséptico facial idiopático" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "X. Wortsman" "autores" => array:1 [ 0 => array:2 [ "nombre" => "X." "apellidos" => "Wortsman" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0001731017306300" "doi" => "10.1016/j.ad.2017.11.006" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731017306300?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219018302208?idApp=UINPBA000044" "url" => "/15782190/0000010900000007/v1_201809020417/S1578219018302208/v1_201809020417/en/main.assets" ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "Opinion Article" "titulo" => "Ertapenem for the treatment of Hidradenitis suppurativa: how much do we need it?" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "582" "paginaFinal" => "583" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "P. Mendes-Bastos, A. Martorell, S. Magina" "autores" => array:3 [ 0 => array:4 [ "nombre" => "P." "apellidos" => "Mendes-Bastos" "email" => array:1 [ 0 => "Pmendesbastos@gmail.com" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "*" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "A." "apellidos" => "Martorell" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "b" "identificador" => "aff0010" ] ] ] 2 => array:3 [ "nombre" => "S." "apellidos" => "Magina" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "c" "identificador" => "aff0015" ] 1 => array:2 [ "etiqueta" => "d" "identificador" => "aff0020" ] ] ] ] "afiliaciones" => array:4 [ 0 => array:3 [ "entidad" => "Centro de Dermatología, Hospital CUF Descobertas, Lisboa, Portugal" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Departamento de Dermatología, Hospital de Manises, Valencia, España" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Departamento de Dermatología y Venereología, Centro Hospitalario de São João, Oporto, Portugal" "etiqueta" => "c" "identificador" => "aff0015" ] 3 => array:3 [ "entidad" => "Departamento de Farmacología y Terapéutica, Facultad de Medicina, Universidad de Oporto, Oporto, Portugal" "etiqueta" => "d" "identificador" => "aff0020" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Ertapenem para el tratamiento de hidradenitis supurativa: ¿en qué medida lo necesitamos?" ] ] "textoCompleto" => "Hidradenitis suppurativa (HS) is a chronic, recurrent and debilitating skin disease of the hair follicle that can be accompanied by systemic inflammation. Many systemic drugs prescribed in HS lack robust evidence supporting its use and personalized therapy must guide the therapeutic decision process. The aim of this letter is discussing the clinical relevance of ertapenem in the control of this chronic disease.The evidence supporting its use is based on a single retrospective study in which Join-Lambert et al demonstrated the efficacy of a 6-week course of intravenous ertapenem followed by consolidation therapy with a triple AB regimen (rifampicin/moxifloxacin/metronidazole) in severe HS patients (LOE IV, SOR C).<a class="elsevierStyleCrossRef" href="#bib0055">1</a> Thirty consecutive patients with severe HS were retrospectively included, having received a 6-week course of intravenous ertapenem (1g daily) followed by 12-week consolidation phase: a 6-week course of rifampicin 10mg/Kg once daily/moxifloxacin 400mg once daily/metronidazole 500mg 3id and a final 6-week of rifampicin and moxifloxacin alone. At 6 months, 16/30 patients had received continuous “consolidation treatments” with other antibiotics after ertapenem; the other 14/30 were either lost to follow-up or received intermittent “consolidation treatments”.<a class="elsevierStyleCrossRef" href="#bib0055">1</a> The authors state that clinical remission was obtained for 100% of Hurley stage I lesions, 96% of Hurley stage II lesions and 27% of Hurley stage III lesions, concluding that a 6-week course of ertapenem can significantly ameliorate severe HS and that consolidation treatments are essential for further improvement and preventing relapses. The complexity of the study design and the obvious need of further AB to prevent/treat flares after the ertapenem induction phase may raise doubts about the long-term effectiveness of this therapeutic choice.Ertapenem and other carbapenemes have a broad-spectrum antibacterial activity, being active against many aerobic and anaerobic gram-positive and gram-negative organisms with a major impact on the gut flora. Resistance in Gram-negative bacteria is increasing at an alarming rate and β-lactamases-mediated carbapenem resistance has now become a serious clinical issue and a public health threat worldwide.<a class="elsevierStyleCrossRef" href="#bib0060">2</a> In the late 20th century, many resistant Gram-negative infections were treated with carbapenems as single therapeutic agents but that overuse of carbapenems resulted in a 69% increase in imipenem-resistant P. aeruginosa.<a class="elsevierStyleCrossRef" href="#bib0065">3</a> Today we are seeing a global dissemination of new multiple broad-spectrum beta-lactamases and multidrug-resistant Enterobacteriaceae.<a class="elsevierStyleCrossRef" href="#bib0060">2</a>The use of topical and systemic antibiotics in HS patients is associated with antimicrobial resistance.<a class="elsevierStyleCrossRef" href="#bib0070">4</a> In our perspective, the therapeutic strategy when treating HS must be decided on an individual basis and rely on short-term treatments to control flares and long-term treatments to control persisting inflammation. Ertapenem is a β-lactamic carbapenem with no anti-inflammatory properties; in fact, it induces bacterial lysis and promotes inflammation.<a class="elsevierStyleCrossRef" href="#bib0075">5</a> Therefore, its effect in improving HS can occur, but mainly through antibacterial mechanisms and should be reserved to control suppurative flares only, i.e., superinfection of HS lesions. Given the risk of randomly using a broad-spectrum AB like ertapenem, determining which seriously affected HS patients would benefit from it is essential. As ertapenem's mode of action is only antibacterial, microbiologic studies with antibiogram analysis should guide the prescribing clinician when considering using this drug.In fact, if a suppurative flare is resistant to tetracyclines or rifampicin/clindamycin combination,<a class="elsevierStyleCrossRef" href="#bib0080">6</a> two actions should be taken into account before considering any broader spectrum antibiotic: to take optimal cultures and to reassess the non-responding skin areas as HS structures such as scarring fistulas are unresponsive to medical therapy and require a surgical intervention.<a class="elsevierStyleCrossRefs" href="#bib0085">7,8</a> Recent studies adding color Doppler ultrasound to improve the accuracy of clinical examination have confirmed that it can significantly modify HS management because of clinical underestimation of severity,<a class="elsevierStyleCrossRefs" href="#bib0095">9,10</a> prompting an earlier combination of medical and surgical treatments.We believe that antibiotics play a very important role in treating superinfection and should be generally prescribed to control flares, in the short-term management of HS. Long-term management should include a personalized combination of medical and surgical strategies, preferably using ultrasound to accurately characterize HS lesions/extension and monitor response to therapy.Conflict of InteresP. Mendes-Bastos has worked as an investigator in clinical studies supported by Abbvie and has been paid as a speaker in events supported by Abbvie. A. Martorell and S. Magina declare no conflicts of interest." "textoCompletoSecciones" => array:1 [ "secciones" => array:2 [ 0 => array:2 [ "identificador" => "sec0005" "titulo" => "Conflict of Interes" ] 1 => array:1 [ "titulo" => "Références" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "Please cite this article as: Mendes-Bastos P, Martorell A, Magina S. Ertapenem para el tratamiento de hidradenitis supurativa: ¿en qué medida lo necesitamos?. Actas Dermosifiliogr. 2018;109:582–853." ] ] "bibliografia" => array:2 [ "titulo" => "Références" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:10 [ 0 => array:3 [ "identificador" => "bib0055" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Efficacy of ertapenem in severe hidradenitis suppurativa: A pilot study in a cohort of 30 consecutive patients" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "O. Join-Lambert" 1 => "H. Coignard-Biehler" 2 => "J. Jais" 3 => "M. Delage" 4 => "H. Guet-Revillet" 5 => "S. Poirée" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/jac/dkv361" "Revista" => array:6 [ "tituloSerie" => "J Antimicrob Chemother" "fecha" => "2016" "volumen" => "71" "paginaInicial" => "513" "paginaFinal" => "520" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26565016" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0060" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The epidemiology of carbapenem-resistant Enterobacteriaceae: The impact and evolution of a global menace" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "L. Logan" 1 => "R. Weinstein" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/infdis/jiw282" "Revista" => array:7 [ "tituloSerie" => "J Infect Dis" "fecha" => "2017" "volumen" => "215" "numero" => "Suppl 1" "paginaInicial" => "S28" "paginaFinal" => "S36" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28375512" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0065" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J. Rahal" 1 => "C. Urban" 2 => "D. Horn" 3 => "K. Freeman" 4 => "S. Segal-Maurer" 5 => "J. Maurer" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "JAMA" "fecha" => "1998" "volumen" => "280" "paginaInicial" => "1233" "paginaFinal" => "1237" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9786372" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0070" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Patterns of antimicrobial resistance in lesions of hidradenitis suppurativa" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "A. Fischer" 1 => "A. Haskin" 2 => "G. Okoye" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jaad.2016.08.001" "Revista" => array:6 [ "tituloSerie" => "J Am Acad Dermatol" "fecha" => "2017" "volumen" => "76" "paginaInicial" => "309" "paginaFinal" => "313" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27742173" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0075" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Immunomodulating effects of antibiotics: Literature review" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "B. Van Vlem" 1 => "R. Vanholder" 2 => "P. De Paepe" 3 => "D. Vogelaers" 4 => "S. Ringoir" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Infection" "fecha" => "1996" "volumen" => "24" "paginaInicial" => "275" "paginaFinal" => "291" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8875279" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0080" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "W. Gulliver" 1 => "C. Zouboulis" 2 => "E. Prens" 3 => "G. Jemec" 4 => "T. Tzellos" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s11154-016-9328-5" "Revista" => array:6 [ "tituloSerie" => "Rev Endocr Metab Disord" "fecha" => "2016" "volumen" => "17" "paginaInicial" => "343" "paginaFinal" => "351" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26831295" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0085" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Update on hidradenitis suppurativa (part II): Treatment" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A. Martorell" 1 => "F. García" 2 => "D. Jiménez-Gallo" 3 => "J. Pascual" 4 => "J. Pereyra-Rodríguez" 5 => "L. Salgado" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ad.2015.06.005" "Revista" => array:6 [ "tituloSerie" => "Actas Dermosifiliogr" "fecha" => "2015" "volumen" => "106" "paginaInicial" => "716" "paginaFinal" => "724" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26277040" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0090" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Surgical procedures in hidradenitis suppurativa" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "I. Janse" 1 => "A. Bieniek" 2 => "B. Horváth" 3 => "L. Matusiak" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.det.2015.08.007" "Revista" => array:6 [ "tituloSerie" => "Dermatol Clin" "fecha" => "2016" "volumen" => "34" "paginaInicial" => "97" "paginaFinal" => "109" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26617363" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0095" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "[Ultrasound examination of hidradenitis suppurativa]" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "A. Martorell" 1 => "J. Segura-Palacios" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S0001-7310(16)30007-2" "Revista" => array:7 [ "tituloSerie" => "Actas Dermosifiliogr" "fecha" => "2015" "volumen" => "106" "numero" => "Suppl 1" "paginaInicial" => "49" "paginaFinal" => "59" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26895939" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0100" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Ultrasound in-depth characterization and staging of hidradenitis suppurativa" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "X. Wortsman" 1 => "C. Moreno" 2 => "R. Soto" 3 => "J. Arellano" 4 => "C. Pezo" 5 => "J. Wortsman" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/dsu.12329" "Revista" => array:6 [ "tituloSerie" => "Dermatol Surg" "fecha" => "2013" "volumen" => "39" "paginaInicial" => "1835" "paginaFinal" => "1842" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24118433" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/15782190/0000010900000007/v1_201809020417/S1578219018301938/v1_201809020417/en/main.assets" "Apartado" => array:4 [ "identificador" => "6152" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Opinion Article" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/15782190/0000010900000007/v1_201809020417/S1578219018301938/v1_201809020417/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219018301938?idApp=UINPBA000044"]